An elastase-inhibiting, plaque-targeting and neutrophil-hitchhiking liposome against atherosclerosis

中性粒细胞弹性蛋白酶 弹性蛋白酶 脂质体 材料科学 医学 炎症 免疫学 药理学 纳米技术 化学 酶 生物化学
作者
Yin Shi,Mei Dong,Yue Wu,Fanglin Gong,Zibin Wang,Lingjing Xue,Zhigui Su
出处
期刊:Acta Biomaterialia [Elsevier BV]
卷期号:173: 470-481 被引量:37
标识
DOI:10.1016/j.actbio.2023.11.020
摘要

Neutrophil extracellular traps (NETs) play a crucial role in the formation of vulnerable plaques and the development of atherosclerosis. Alleviating the pathological process of atherosclerosis by efficiently targeting neutrophils and inhibiting the activity of neutrophil elastase to inhibit NETs is relatively unexplored and is considered a novel therapeutic strategy with clinical significance. Sivelestat (SVT) is a second-generation competitive inhibitor of neutrophil elastase with high specificity. However, therapeutic effect of SVT on atherosclerosis is restricted because of the poor half-life and the lack of specific targeting. In this study, we construct a plaque-targeting and neutrophil-hitchhiking liposome (cRGD-SVT-Lipo) to improve the efficacy of SVT in vivo by modifying the cRGD peptide onto SVT loaded liposome, which was based on the interaction between cRGD peptide and integrin ανβ3 on the surface of cells in blood and plaque, including epithelial cell, macrophage and neutrophils. The cRGD-SVT-Lipo could actively tend to or hitchhike neutrophils in situ to reach atherosclerotic plaque, which resulted in enhanced atherosclerotic plaque delivery. The cRGD-SVT-Lipo could also reduce plaque area, stabilize plaque, and ultimately alleviate atherosclerosis progression through efficiently inhibiting the activity of neutrophil elastase in atherosclerotic plaque. Therefore, this study provides a basis and targeting strategy for the treatment of neutrophil-related diseases. Neutrophil extracellular traps (NETs)-inhibiting is a prospective therapeutic approach for atherosclerosis but has received little attention. The NETs can be inhibited by elastase-restraining. In this work, an intriguing system that delivers Sivelestat (SVT), a predominantly used neutrophil elastase inhibitor with poor targeting capability, is designed to provide the drug with plaque-targeting and neutrophil-hitchhiking capability. The result suggests that this system can effectively hinder the formation of NETs and delay the progression of atherosclerosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
威武的凡双完成签到,获得积分10
刚刚
xujunjie完成签到,获得积分10
刚刚
1秒前
1234发布了新的文献求助10
3秒前
心之所向878完成签到,获得积分10
4秒前
Gaiiw发布了新的文献求助10
4秒前
5秒前
成就的问枫完成签到 ,获得积分10
5秒前
wanci的应助被jeff采纳,获得10
5秒前
浪荡的小可完成签到,获得积分10
6秒前
我有神光棒完成签到,获得积分10
6秒前
威武的沂完成签到,获得积分10
6秒前
Zoe_Zhang完成签到,获得积分10
6秒前
6秒前
深情安青的应助被懵懂的听枫采纳,获得10
6秒前
小艾发布了新的文献求助10
7秒前
清脆紫烟发布了新的文献求助10
7秒前
7秒前
烟花的应助被噗喵喵采纳,获得10
8秒前
阿May发布了新的文献求助10
9秒前
GFFino完成签到 ,获得积分10
10秒前
GZH完成签到,获得积分10
10秒前
ygchyh完成签到,获得积分10
11秒前
lilili发布了新的文献求助10
12秒前
12秒前
13秒前
之鱼之乐发布了新的文献求助10
13秒前
好听点啊完成签到 ,获得积分10
14秒前
15秒前
molihuakai的应助被东京蔡徐坤采纳,获得10
15秒前
Maestro_S的应助被renn采纳,获得30
15秒前
一叶瓷完成签到,获得积分10
15秒前
尘远知山静完成签到 ,获得积分10
16秒前
16秒前
宋囡囡完成签到,获得积分10
19秒前
zrj完成签到,获得积分10
19秒前
20秒前
王小拉完成签到 ,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184061
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829878
捐赠科研通 7781058
什么是DOI,文献DOI怎么找? 3434216
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480674